The short chain fatty acid sodium butyrate regulates the induction of CD1a in developing dendritic cells

Immunobiology

Volumn 216, Issue 3, 2011, Pages 275-284

  Nascimento, Clarissa Rodrigues ^a   Freire de Lima, Célio G ^a   da Silva de Oliveira, Andréia ^a   Rumjanek, Franklin D ^a   Rumjanek, Vivian M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Cell surface molecules; Dendritic cells; Differentiation; Flow cytometry; Monocytes

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; BUTYRIC ACID; CD11B ANTIGEN; CD14 ANTIGEN; CD83 ANTIGEN; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 4; MESSENGER RNA; RECEPTOR BLOCKING AGENT; SHORT CHAIN FATTY ACID; T6 ANTIGEN; TOLL LIKE RECEPTOR 2;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL STRUCTURE; CELL VIABILITY; COLONY FORMING CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 79251598810     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2010.07.004     Document Type: Article

References (38)

1. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767-811.
2. Belge K.U., Dayyani F., Horelt A., Siedlar M., Frankenberger M., Frankenberger B., Espevik T., Ziegler-Heitbrock L. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J. Immunol. 2002, 168(7):3536-3542.
3. Bernhard D., Ausserlechner M.J., Tonko M., Löffler M., Hartmann B.L., Csordas A., Kofler R. Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts. FASEB J. 1999, 13:1991-2001.
4. Bi G., Jiang G. The molecular mechanism of HDAC inhibitors in anticancer effects. Cell. Mol. Immunol. 2006, 3:285-290.
5. Bolden J.E., Peart M.J., Johnstone R.W. Anticancer activities of histone deacetylase inhibitors. Nat. Rev. Drug Discov. 2006, 5(9):769-784.
6. Brogdon J.L., Xu Y., Szabo S.J., An S., Buxton F., Cohen D., Huang Q. Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function. Blood 2007, 109:1123-1130.
7. Chang C.C., Wright A., Punnonen J. Monocyte-derived CD1a+ and CD1a- dendritic cell subsets differ in their cytokine production profiles, susceptibilities to transfection, and capacities to direct Th cell differentiation. J. Immunol. 2000, 165:3584-3591.
8. D'Argenio G., Mazzacca G. Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer. Adv. Exp. Med. Biol. 1999, 472:149-158.
9. Freudenthal P.S., Steinman R.M. The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:7698-7702.
10. Fusunyan R.D., Quinn J.J., Fujimoto M., MacDermott R.P., Sanderson I.R. Butyrate switches the pattern of chemokine secretion by intestinal epithelial cells through histone acetylation. Mol. Med. 1999, 5:631-640.
11. Hamilton J.A. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 2008, 8:533-544.
12. Hunger R.E., Sieling P.A., Ochoa M.T., Sugaya M., Burdick A.E., Rea T.H., Brennan P.J., Belisle J.T., Blauvelt A., Porcelli S.A., Modlin R.L. Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. J. Clin. Invest. 2004, 113(5):701-708.
13. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293:1074-1080.
14. Kitamura K., Hoshi S., Koike M., Kiyoi H., Saito H., Naoe T. Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-trans retinoic acid. Br. J. Haematol. 2000, 108:696-702.
15. Leoni F., Zaliani A., Bertolini G., Porro G., Pagani P., Pozzi P., Donà G., Fossati G., Sozzani S., Azam T., Bufler P., Fantuzzi G., Goncharov I., Kim S.H., Pomerantz B.J., Reznikov L.L., Siegmund B., Dinarello C.A., Mascagni P. The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:2995-3000.
16. Leslie D.S., Dascher C.C., Cembrola K., Townes M.A., Hava D.L., Hugendubler L.C., Mueller E., Fox L., Roura-Mir C., Moody D.B., Vincent M.S., Gumperz J.E., Illarionov P.A., Besra G.S., Reynolds C.G., Brenner M.B. Serum lipids regulate dendritic cell CD1 expression and function. Immunology 2008, 125(3):289-301.
17. Millard A.L., Mertes P.M., Ittelet D., Villard F., Jeannesson P., Bernard J. Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages. Clin. Exp. Immunol. 2002, 130:245-255.
18. Mori L., De Libero G. Presentation of lipid antigens to T cells. Immunol. Lett. 2008, 117(1):1-8.
19. Naik S.H. Demystifying the development of dendritic cell subtypes, a little. Immunol. Cell Biol. 2008, 86(5):439-452.
20. Nencioni A., Beck J., Werth D., Grünebach F., Patrone F., Ballestrero A., Brossart P. Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity. Clin. Cancer Res. 2007, 13:3933-3941.
21. Nencioni A., Grünebach F., Zobywlaski A., Denzlinger C., Brugger W., Brossart P. Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor gamma. J. Immunol. 2002, 169(3):1228-1235.
22. Randolph G.J., Sanchez-Schmitz G., Liebman R.M., Schäkel K. The CD16(+) (FcgammaRIII(+)) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J. Exp. Med. 2002, 196(4):517-527.
23. Romani N., Gruner S., Brang D., Kämpgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P.O., Steinman R.M., Schuler G. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 1994, 180:83-93.
24. Roura-Mir C., Wang L., Cheng T.Y., Matsunaga I., Dascher C.C., Peng S.L., Fenton M.J., Kirschning C., Moody D.B. Mycobacterium tuberculosis regulates CD1 antigen presentation pathways through TLR-2. J. Immunol. 2005, 175(3):1758-1766.
25. Säemann M.D., Böhmig G.A., Osterreicher C.H., Burtscher H., Parolini O., Diakos C., Stöckl J., Hörl W.H., Zlabinger G.J. Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J. 2000, 14:2380-2382.
26. Sallusto F., Cella M., Danieli C., Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 1995, 182:389-400.
27. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994, 179(4):1109-1118.
28. Santegoets S.J., Gibbs S., Kroeze K., van de Ven R., Scheper R.J., Borrebaeck C.A., de Gruijl T.D., Lindstedt M. Transcriptional profiling of human skin-resident Langerhans cells and CD1a+ dermal dendritic cells: differential activation states suggest distinct functions. J. Leukoc. Biol. 2008, 84(1):143-151.
29. Shortman K., Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 2007, 7:19-30.
30. Smed-Sörensen A., Moll M., Cheng T.Y., Loré K., Norlin A.C., Perbeck L., Moody D.B., Spetz A.L., Sandberg J.K. IgG regulates the CD1 expression profile and lipid antigen-presenting function in human dendritic cells via FcgammaRIIa. Blood 2008, 111(10):5037-5046.
31. Szatmari I., Gogolak P., Im J.S., Dezso B., Rajnavolgyi E., Nagy L. Activation of PPARgamma specifies a dendritic cell subtype capable of enhanced induction of iNKT cell expansion. Immunity 2004, 21(1):95-106.
32. Szatmari I., Nagy L. Nuclear receptor signalling in dendritic cells connects lipids, the genome and immune function. EMBO J. 2008, 27(18):2353-2362.
33. Szatmari I., Pap A., Rühl R., Ma J.X., Illarionov P.A., Besra G.S., Rajnavolgyi E., Dezso B., Nagy L. PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J. Exp. Med. 2006, 203(10):2351-2362.
34. Szatmari I., Rajnavolgyi E., Nagy L. PPARgamma, a lipid-activated transcription factor as a regulator of dendritic cell function. Ann. N. Y. Acad. Sci. 2006, 1088:207-218.
35. Wang B., Morinobu A., Horiuchi M., Liu J., Kumagai S. Butyrate inhibits functional differentiation of human monocyte-derived dendritic cells. Cell. Immunol. 2008, 253:54-58.
36. Xie J., Qian J., Wang S., Freeman M.E., Epstein J., Yi Q. Novel and detrimental effects of lipopolysaccharide on in vitro generation of immature dendritic cells: involvement of mitogen-activated protein kinase p38. J. Immunol. 2003, 171(9):4792-4800.
37. Zapata-Gonzalez F., Rueda F., Petriz J., Domingo P., Villarroya F., Diaz-Delfin J., de Madariaga M.A., Domingo J.C. Human dendritic cell activities are modulated by the omega-3 fatty acid, docosahexaenoic acid, mainly through PPAR(gamma):RXR heterodimers: comparison with other polyunsaturated fatty acids. J. Leukoc. Biol. 2008, 84(4):1172-1182.
38. Zhou L.J., Tedder T.F. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:2588-2592.